About General transcription factor IIH subunit 2
General transcription factor IIH subunit 2 (GTF2H2) is a protein
from Homo sapiens identified by UniProt accession
Q13888, 395 residues long.
MolForge cross-references it against 0 known binders and
30 disease associations.
Target properties
| Protein name | General transcription factor IIH subunit 2 |
| UniProt accession | Q13888 |
| Gene | GTF2H2 |
| Organism | Homo sapiens |
| Length | 395 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (30)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.59
- neurodegenerative disease · score 0.54
- total blood protein measurement · score 0.26
- squamous cell lung carcinoma · score 0.18
- mean corpuscular volume · score 0.17
- clear cell renal carcinoma · score 0.17
- platelet component distribution width · score 0.14
- urinary bladder cancer · score 0.12
- blood protein measurement · score 0.07
- severe malarial anemia · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13888-F1 | alphafold | PREDICTED | 84.33 | — |
Amino-acid sequence (395 residues)
MDEEPERTKR WEGGYERTWE ILKEDESGSL KATIEDILFK AKRKRVFEHH GQVRLGMMRH LYVVVDGSRT MEDQDLKPNR LTCTLKLLEY FVEEYFDQNP ISQIGIIVTK SKRAEKLTEL SGNPRKHITS LKKAVDMTCH GEPSLYNSLS IAMQTLKHMP GHTSREVLII FSSLTTCDPS NIYDLIKTLK AAKIRVSVIG LSAEVRVCTV LARETGGTYH VILDESHYKE LLTHHVSPPP ASSSSECSLI RMGFPQHTIA SLSDQDAKPS FSMAHLDGNT EPGLTLGGYF CPQCRAKYCE LPVECKICGL TLVSAPHLAR SYHHLFPLDA FQEIPLEEYN GERFCYGCQG ELKDQHVYVC AVCQNVFCVD CDVFVHDSLH CCPGCIHKIP APSGV
Explore General transcription factor IIH subunit 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets